Shares of CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Stock Performance
About CardioGenics
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Further Reading
- Five stocks we like better than CardioGenics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- 5 discounted opportunities for dividend growth investors
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Should You Invest in Penny Stocks?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
